Business Model vs. Go-to-Market: Yes, They’re Different (And It Matters)
When I first encountered TAM, SAM, and SOM, I had no idea what they were. I know that many founders, don’t know either. Let’s analyze them together.
Investors
What Kills a Bioconvergence Pitch (It’s Not the Science)
Your Pitch Isn’t Broken. Your Business Model Is. What a Harvard professor, an AI engineer, and a very uncomfortable VC meeting taught me about bioconvergence startups A seasoned physician. Former Harvard faculty. Decades of clinical insight into how healthcare systems actually work, not in theory, but in the messy, bureaucratic, beautifully dysfunctional reality of it.His […]
